TP53 and breast cancer: Consistent with the original studies21,22, parous Blg-Cre;Brca1f/f;Trp53+/− mice showed an incidence of mammary tumor of 59.3% (16/27) with a mean latency of 36.8 weeks (95% CI, 31.8–41.7 weeks).